Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin Receptor Agonists in Septic Shock
NCT00995839Phase 3Completed
- Sponsor
- Sapienza University of Rome
- Start
- Nov 2008
- Primary completion
- Feb 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of terlipressin, vasopressin in septic shock, sponsored by Sapienza University of Rome. Started Nov 2008; status: completed.
02
Drugs
terlipressinvasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00995839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995839.